2016
DOI: 10.1016/j.plefa.2016.05.003
|View full text |Cite
|
Sign up to set email alerts
|

Astrocyte arachidonate and palmitate uptake and metabolism is differentially modulated by dibutyryl-cAMP treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 93 publications
0
1
0
Order By: Relevance
“…To test the protective effects of tibolone during metabolic inflammation in astrocytes we defined three different metabolic scenarios: (1) A "healthy" scenario, where the rate of palmitate uptake was set freely by the optimizer. This scenario emulates the normal conditions of astrocytes metabolism (Supplementary Data Sheet 1), without any inflammatory response (Seeger et al, 2016). (2) An "induced inflammation by palmitate" scenario, where the uptake rate of palmitate was forced to be stable in the mean of the half maximal inhibitory concentration (IC 50 ) value for all the objective functions included in Table 1.…”
Section: Metabolic Scenariosmentioning
confidence: 99%
“…To test the protective effects of tibolone during metabolic inflammation in astrocytes we defined three different metabolic scenarios: (1) A "healthy" scenario, where the rate of palmitate uptake was set freely by the optimizer. This scenario emulates the normal conditions of astrocytes metabolism (Supplementary Data Sheet 1), without any inflammatory response (Seeger et al, 2016). (2) An "induced inflammation by palmitate" scenario, where the uptake rate of palmitate was forced to be stable in the mean of the half maximal inhibitory concentration (IC 50 ) value for all the objective functions included in Table 1.…”
Section: Metabolic Scenariosmentioning
confidence: 99%